Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Oligo Therapeutics designs completely new class of antimicrobial agents

Oct. 6, 1999

Over 10 abstracts related to nonfluoroquinolones presented by P&G at ICAAC

Oct. 6, 1999

New tricyclic acylides exhibit improved antibacterial activity

Oct. 6, 1999

Acylides as new third-generation macrolide antibiotics

Oct. 6, 1999

More good news for flu drug: oseltamivir featured in JAMA article

Oct. 6, 1999

P&U reports advance in the field of oxazolidinone antibacterials at ICAAC

Oct. 6, 1999

Bacterial efflux pump inhibitors developed at Microcide and presented at ICAAC meeting

Oct. 5, 1999

New class of oxazolidinones with broader spectrum presented at ICAAC by Pharmacia & Upjohn

Oct. 5, 1999

Lipopeptide synthesized at Abbott may be therapeutically useful antifungal agent

Oct. 5, 1999

Potent phenylisoxazoline antimicrobial agents designed at Pharmacia & Upjohn

Oct. 5, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...